FDA rejects long-acting version of Zyprexa
February 29, 2008Sales and Marketing
Lilly has suffered a setback after the US medicines regulator rejected a new version of its top-selling product Zyprexa. The …
Working with NICE: the ingredients for success
February 29, 2008Research and Development, Sales and Marketing NICE, healthcare, industry relations, pharma
NICE fascinates everyone in the industry, and NICE knows only too well that every move it makes is studied by …
Avastin receives surprise FDA approval
February 29, 2008Sales and Marketing
The FDA gone against the advice of its own advisory panel to approve Genentech's Avastin as a first-line treatment for …
AstraZeneca fined $200m over Medicaid pricing
February 29, 2008Sales and Marketing
A US court has ruled AstraZeneca must pay more than $200 million for inflating the prices of drugs prescribed under …
Latest news from Datamonitor
February 28, 2008Sales and Marketing
Algeta to initiate US clinical trials for prostate cancer drug Cancer therapeutics company Algeta has said that it will commence …
GlaxoSmithKline’s Tyverb poised for launch in the UK
February 27, 2008Research and Development
GlaxoSmithKline says its new breast cancer drug Tyverb is ready for launch and could be prescribed to the first UK …
Health comms agency Hive launched
February 27, 2008Medical Communications
A group of experienced healthcare communications executives have launched Hive which they claim represents a 'next generation' of agency to …
Boehringer Ingelheim’s anti-clotting pill ready for launch
February 15, 2008Research and Development
Boehringer Ingelheim's Pradaxa is expected to gain final regulatory approval shortly and could make a major impact in the anti-thrombosis …
Latest news from Datamonitor
February 15, 2008Research and Development
Introgen and Moffitt initiate Phase II lung cancer trial Introgen Therapeutics and Moffitt Cancer Center have reported that a randomized, …
Generics and Avandia decline will hold GSK back
February 8, 2008Sales and Marketing
GlaxoSmithKline's chief executive-in-waiting Andrew Witty faces a difficult first year at the helm of the company after sales growth was …
Vectibix launched for bowel cancer in UK
February 8, 2008Sales and Marketing colorectal cancer
Vectibix, a new treatment for advanced colorectal cancer, has been launched in the UK. The treatment from Amgen was first …
NHS launches new online health A-Z index
February 8, 2008Medical Communications
NHS Choices, the online 'front door' for the NHS, has released an updated online information resource aimed at helping the …
Ministers press GPs over surgery hours
February 8, 2008Government and BMA relations have hit an all time low, with the doctor's association accusing ministers of undermining its position …
Wellcome Trust boosts medical research funding
February 8, 2008Research and Development
Research charity the Wellcome Trust will increase its funding for medical research by more than £1 billion over the next …
Biovitrum to focus on specialist care
February 8, 2008Research and Development
Swedish biopharmaceutical company Biovitrum is to turn its back on mass market disease areas and re-focus around specialist care projects. …
Latest news from Datamonitor
February 6, 2008Sales and Marketing Coronado Biosciences, rnai
Coronado Biosciences’ cancer treatment effective in animal modelsCoronado Biosciences has reported that the Bcl-2 inhibitor, apogossypol, effectively killed a variety …
